Skip to main content
Equibles

Robertson Stephens Wealth Management, LLC

Position in DYAI — Dyadic International Inc

CIK 1767307 San Francisco, CA
Back to DYAI Full portfolio

Position in DYAI

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$26,972
+$2,398 QoQ
Shares Held
29,969
0.0% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 39 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in DYAI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Robertson Stephens Wealth Management, LLC holds $4,144,185 across 13 Biotechnology names. DYAI ranks #12 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MRNA
Moderna, Inc.
 14,682 $1,028,180
2 ALNY
Alnylam Pharmaceuticals, Inc.
 2,782 $837,465
3 INCY
Incyte Corp
 6,672 $756,337
4 CTMX
CytomX Therapeutics, Inc.
 96,000 $360,000
5 CUE
Cue Biopharma, Inc.
 11,133 $351,357
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 420 $208,626
7 RLMD
Relmada Therapeutics, Inc.
 25,000 $173,000
8 ACHV
Achieve Life Sciences, Inc.
 25,000 $163,250

All Filings in DYAI

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $26,972 29,969
2026-03-31 $24,574 29,969
2025-12-31 $28,170 29,969
2025-09-30 $35,363 29,969
2025-06-30 $29,669 29,969
2025-03-31 $40,458 29,969
2024-12-31 $52,445 29,969
2024-09-30 $31,167 29,969
2024-06-30 $73,954 49,969